To tłumaczenie jest jeszcze przygotowywane. Poniżej prezentujemy tymczasowo oryginalną wersję angielską.
Biznes · 8.08.20031 min czytania
Agency Information Collection Activities; Announcement of OMB Approval; Applications for FDA Approval to Market a New Drug: Patent Submission and Listing Requirements and Application of 30-Month Stays on Approval of Abbreviated New Drug Applications Certifying That a Patent Claiming a Drug Is Invalid or Will Not Be Infringed
Automatyczne tłumaczenie lokalne · Oryginalny język źródła
Streszczenie
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Applications for FDA Approval to Market a New Drug: Patent Submission and Listing Requirements and Application of 30-Month Stays on Approval of Abbreviated New Drug Applications Certifying That a Patent Claiming a Drug Is Invalid or Will Not Be Infringed" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Oryginalny język źródła: Federal Register — Food and Drug AdministrationOtwórz oryginalny komunikat →